Trial intelligence / Profile preview

Neural Basis of Interoceptive Dysfunction in Anorexia Nervosa

NCT02615119Completed

Start
Oct 2015
Primary completion
Jun 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of isoprenaline (6 arms). Primary endpoint: Change in cardiorespiratory sensation intensity. Started Oct 2015; status: completed.

02

Drugs

isoprenaline

Beyond the preview

Go deeper on NCT02615119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02615119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call